KBRA Comments on Amendment to Sunnovas Loan Guarantee Agreement with DOE
NEW YORK--(BUSINESS WIRE)--#creditratingagency--In an 8-K filing with the Securities and Exchange Commission…
Herbalife India Launches New Podcast Series – Live Your Best Life, Unscripted
The debut episode explores holistic wellness, mental resilience, and performance strategies with…
OMAN CREDIT OUTLOOK STRENGTHENS AS OIA REFORMS DRIVE FINANCIAL RESILIENCE
MUSCAT, Oman, April 16, 2025 /PRNewswire/ -- The Sultanate of Oman's recent…
NeuroQuiet Reviews (Complaints & Side Effects): Buyers Reveal Unexpected Truths Behind Its Real Effectiveness & Safety
VANCOUVER, WA, March 29, 2025 (GLOBE NEWSWIRE) -- NeuroQuiet Reviews In a…
Dupixent (dupilumab) Late-Breaking Positive Pivotal Data in Bullous Pemphigoid Presented at AAD
Five times more adults on Dupixent achieved sustained disease remission at 36…
China Unicom, YunHuan Technology and ZTE win the GSMA GLOMO “Best Mobile Innovation for Cities” award
BARCELONA, Spain, March 6, 2025 /PRNewswire/ -- ZTE Corporation (0763.HK / 000063.SZ),…
RYAM Announces Impressive Fourth Quarter and Full Year 2024 Results and Provides 2025 Guidance
Net sales for 2024 of $1,630 million, down $13 million from the…
Celldex Therapeutics Presents Positive Results from Barzolvolimab Phase 2 Studies in Patients with Chronic Urticaria Demonstrating Improved Disease Control and Quality of Life at AAAAI 2025
March 01, 2025 12:45 ET | Source: Celldex Therapeutics, Inc. - Greatly…
Positive results from the TEZSPIRE Phase III WAYPOINT trial highlight rapid and sustained effect in chronic rhinosinusitis with nasal polyps
TEZSPIRE significantly reduced nasal congestion, polyp size and nearly eliminated the need…
DuelNow Launches $DNOW Token Delivering Membership Rewards for Users
LISBON, Portugal, Feb. 7, 2025 /PRNewswire/ -- DuelNow – the trailblazing sports prediction…